AAAAAA
Results:
1-15
|
Results: 15
Authors:
Lissoni, P
Malugani, F
Bonfanti, A
Bucovec, R
Secondino, S
Brivio, F
Ferrari-Bravo, A
Ferrante, R
Vigore, L
Rovelli, F
Mandala, M
Viviani, S
Fumagalli, L
Gardani, GS
Citation: P. Lissoni et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulatingdendritic cells, IL-12 and endothelin-1, J BIOL REG, 15(2), 2001, pp. 140-144
Authors:
Cerea, K
Romano, F
Bravo, AF
Motta, V
Uggeri, F
Brivio, F
Fumagalli, LA
Uggeri, F
Citation: K. Cerea et al., Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients, J SURG ONC, 78(1), 2001, pp. 32-37
Authors:
Lissoni, P
Brivio, F
Rovelli, F
Fumagalli, G
Malugani, F
Vaghi, N
Secondino, S
Bucovec, R
Gardani, GS
Citation: P. Lissoni et al., Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease, J BIOL REG, 14(4), 2000, pp. 275-277
Authors:
Brivio, F
Lissoni, P
Gilardi, R
Ferrante, R
Vigore, L
Curzi, L
Uggeri, F
Nespoli, A
Fumagalli, L
Citation: F. Brivio et al., Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients, J BIOL REG, 14(3), 2000, pp. 200-203
Authors:
Milani, M
Costato, M
Brivio, F
Casati, R
Cattaneo, G
Magni, F
Pistoni, NC
Previdi, F
Spinoglio, L
Citation: M. Milani et al., A critical analysis of radiation-matter interaction, RIV NUOV CI, 23(8), 2000, pp. 1-59
Authors:
Bonfanti, A
Lissoni, P
Bucovec, R
Rovelli, F
Brivio, F
Fumagalli, L
Citation: A. Bonfanti et al., Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer, INT J B MAR, 15(2), 2000, pp. 161-164
Authors:
Lissoni, P
Brivio, F
Ferrante, R
Vigore, L
Vaghi, M
Fumagalli, E
Bucovec, R
Malugani, F
Fumagalli, L
Citation: P. Lissoni et al., Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer, INT J B MAR, 15(1), 2000, pp. 22-25
Authors:
Lissoni, P
Mandala, M
Brivio, F
Citation: P. Lissoni et al., Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin, EUR UROL, 38(1), 2000, pp. 115-118
Authors:
Lissoni, P
Bolis, S
Brivio, F
Fumagalli, L
Citation: P. Lissoni et al., A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies, ANTICANC R, 20(3B), 2000, pp. 2103-2105
Authors:
Brivio, F
Gilardi, R
Bucocev, R
Ferrante, R
Rescaldani, R
Vigore, L
Fumagalli, L
Nespoli, A
Lissoni, P
Citation: F. Brivio et al., Surgery-induced decline in circulating dendritic cells in operable cancer patients: A possible explanation of postoperative immunosuppression, HEP-GASTRO, 47(35), 2000, pp. 1337-1339
Authors:
Brivio, F
Lissoni, P
Fumagalli, L
Girlando, M
Marsili, MT
Nespoli, A
Uggeri, F
Citation: F. Brivio et al., Pre-operative IL-2 immunoprophylaxis of cancer recurrence: Long-term clinical results of a phase II study in radically operable colorectal cancer, ONCOL REP, 6(6), 1999, pp. 1205-1207
Authors:
Lissoni, P
Brivio, F
Viviani, S
Fumagalli, L
Citation: P. Lissoni et al., Which immunological parameters ave clinically essential to monitor IL-2 cancer immunotherapy?, J BIOL REG, 13(2), 1999, pp. 110-114
Authors:
Lissoni, P
Mandala, M
Giani, L
Brivio, F
Paolorossi, F
Bordoni, A
Fumagalli, L
Citation: P. Lissoni et al., Negative influence of morphine on the efficacy of interleukin-2 cancer immunotherapy, INT J IMM T, 15(1), 1999, pp. 31-34
Authors:
Lissoni, P
Laudon, M
Barni, S
Brivio, F
Tisi, E
Rovelli, F
Chatikhine, V
Fumagalli, L
Maestroni, GJM
Conti, A
Tancini, G
Citation: P. Lissoni et al., Long-term results of cancer immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin, INT J IMM T, 14(3), 1998, pp. 169-174
Authors:
Lissoni, P
Fumagalli, L
Rovelli, F
Brivio, F
Di Felice, G
Majorca, F
Citation: P. Lissoni et al., In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients, BR J CANC, 77(11), 1998, pp. 1957-1960
Risultati:
1-15
|